This study opens the way to other perspectives (1) an in depth molecular and metabolomic exploration of synergistic action of the CRA-CGA couple on insulin secretion, insulin sensitivity and antioxidant signaling pathways and (2) by a clinical trial on METS patients with obesity and elevated risk of cardiovascular disease. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.